Overview
CNS vasculitis
Autoimmune encephalitis
Juvenile arthritis
Systemic vasculitis
Autoimmune encephalitis
Juvenile arthritis
Systemic vasculitis
Current Appointments & Affiliations
Associate Professor of Pediatrics
·
2021 - Present
Pediatrics, Rheumatology,
Pediatrics
Chief, Division of Rheumatology
·
2020 - Present
Pediatrics, Rheumatology,
Pediatrics
Recent Publications
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
Journal Article Pediatr Rheumatol Online J · October 21, 2025 BACKGROUND: Systemic juvenile idiopathic arthritis (SJIA) is a severe form of juvenile idiopathic arthritis characterized by fever, rash, chronic arthritis, and systemic inflammation. The introduction of biologics has improved the treatment options for SJI ... Full text Link to item CiteDisease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registry.
Journal Article Pediatr Rheumatol Online J · July 22, 2025 OBJECTIVE: To account for the chronic time course of juvenile idiopathic arthritis (JIA), we assessed medication changes by disease activity patterns across 2 sequential timepoints. METHODS: Patients with non-systemic JIA enrolled in the Childhood Arthriti ... Full text Link to item CiteRetrospective Comparison of Patients Evaluated for Pediatric Autoimmune Encephalitis with Typical and Atypical Premorbid Neuropsychiatric Development.
Journal Article J Autism Dev Disord · June 2025 PURPOSE: Patients with neurodevelopmental disorders (NDD) (i.e. autism, developmental delay, early-onset psychiatric or seizure disorders) increasingly seek evaluation of new or exacerbated symptoms concerning for autoimmune encephalitis (AE). Clinical AE ... Full text Link to item CiteRecent Grants
Phase 2/3, Children and Adolescents With Aquaporin-4 antibody Positive (AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)
Clinical TrialPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2024 - 2026Phase III EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2025 - 2026Arthritis Foundation Fellowship Training Grant 2019
FellowshipCo Investigator · Awarded by Arthritis Foundation · 2020 - 2024View All Grants
Education, Training & Certifications
University of Rochester ·
2001
M.D.